Mesoporous
silicon (PSi) nanoparticles have been widely studied in different
biomedical imaging modalities due to their several beneficial material
properties. However, they have not been found to be suitable for photoacoustic
imaging due to their poor photothermal conversion performance. In
the present study, biodegradable black mesoporous silicon (BPSi) nanoparticles
with strong light absorbance were developed as superior image contrast
agents for photoacoustic tomography (PAT), which was realized with
a light-emitting diode (LED) instead of the commonly used laser. LED-based
PAT offers the advantages of low cost, compactness, good mobility,
and easy operation as compared to the traditional laser-based PAT
modality. Nevertheless, the poor imaging sensitivity of the LED-PAT
systems has been the main barrier to prevent their wide biomedical
application because the LED light has low optical energy. The present
study demonstrated that the imaging sensitivity of the LED-PAT system
was significantly enhanced with the PEGylated BPSi (PEG–BPSi)
nanoparticles. The PEG–BPSi nanoparticles were clearly detectable
with a low concentration of 0.05 mg/mL in vitro and with an LED radiation
energy of 5.2 μJ. The required concentration of the PEG–BPSi
nanoparticles was 10 times lesser than that of the reference gold
nanoparticles to reach the corresponding level of the imaging contrast.
The ex vivo studies demonstrated that the submillimeter BPSi nanoparticle-based
absorbers were distinguishable in chicken breast tissues. The strong
contrast provided by the BPSi particles indicated that these particles
can be utilized as novel contrast agents in PAT, especially in LED-based
systems with low light intensity.
Inorganic photothermal agents (PTAs) have attracted considerable attention in cancer theranostics due to their unique features such as high photothermal conversion efficacy, excellent photothermal stability, and straightforward functionalization. The first part of this Review summarizes progress in methods for synthesizing PTAs, then considers in vitro photothermal evaluations, as well as in vivo photothermal-based applications that attempt to overcome different barriers in cancer theranostics. Next, a clinical trial with an inorganic PTA is described. The final part of the Review examines the challenges and possibilities for successful transfer of inorganic PTAs from the laboratory to the clinic.
Complex experimental design is a common problem in the preparation of theranostic nanoparticles, resulting in poor reaction control, expensive production cost, and low experiment success rate. The present study aims to develop PEGylated bismuth (PEG-Bi) nanoparticles with a precisely controlled one-pot approach, which contains only methoxy[(poly-(ethylene glycol)]trimethoxy-silane (PEG-silane) and bismuth oxide (Bi 2 O 3 ). A targeted pyrolysis of PEG-silane was achieved to realize its roles as both the reduction and PEGylation agents. The unwanted methoxy groups of PEG-silane were selectively pyrolyzed to form reductive agents, while the useful PEG-chain was fully preserved to enhance the biocompatibility of Bi nanoparticles. Moreover, Bi 2 O 3 not only acted as the raw material of the Bi source but also presented a self-promotion in the production of Bi nanoparticles via catalyzing the pyrolysis of PEG-silane. The reaction mechanism was systematically validated with different methods such as nuclear magnetic resonance spectroscopy. The PEG-Bi nanoparticles showed better compatibility and photothermal conversion than those prepared by the complex multiple step approaches in literature studies. In addition, the PEG-Bi nanoparticles possessed prominent performance in X-ray computed tomography imaging and photothermal cancer therapy in vivo. The present study highlights the art of precise reaction control in the synthesis of PEGylated nanoparticles for biomedical applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.